New Cryopreserved Human Primary Cell Lines Now Available

Two new, well-defined, cryopreserved human cell lines are now available for biotech and other life science researchers.

The new “Cryo-M Human Monocytes” and “Cryo-T4 Human CD4+ T-Cells” have been added to SeraCare Life Sciences’ (Milford, MA, USA) “AccuCell Peripheral Blood Mononuclear Cell (PBMC)” portfolio.

These types of cryopreserved primary cells are especially valuable for use in the study of autoimmune diseases, inflammatory diseases, oncology, and infectious diseases. SeraCare attests that these products are highly pure primary cells with greater than 90% viability.

“The availability of large lots from the same donor provides a significant advantage for investigators, especially those performing longitudinal studies, as it greatly reduces study variability and facilitates consistency and reproducibility,” said Tina Patel, associate technical product manager at SeraCare Life Sciences. “SeraCare’s extensive sourcing network and donor program also enables the company to potentially contact the same donors for additional draws.”

In addition to the “off-the-shelf” Cryo-M and Cryo-T4 Human PBMC subsets, which include a broad range of donor demographics and related HLA information, SeraCare can provide cryopreserved cells customized to individual customer needs including disease-specific, allergen-specific, and genotype-specific options.

Related Links:
SeraCare Life Sciences